Literature DB >> 531044

The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate.

B Högberg, P Björk, K Carlström, B Forsgren, J A Gustafsson, T Hökfelt, A Pousette.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 531044

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  6 in total

1.  Production of monoclonal antibody against the C1 component of rat estramustine-binding protein: immunohistochemical study of rat prostate.

Authors:  Y Tamura; H Yuasa; T Suzuki; H Yamanaka; K Suzuki
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

2.  Estramustine-binding protein in malignant glioma in rat.

Authors:  A E Karlsson; P Björk; A T Bergenheim; J Sandström; H Hedman; R Henriksson
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

Review 3.  Pharmacokinetics and pharmacodynamics of estramustine phosphate.

Authors:  A T Bergenheim; R Henriksson
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 4.  Estramustine in malignant glioma.

Authors:  A T Bergenheim; R Henriksson; J M Piepmeier; D Yoshida
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

5.  Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.

Authors:  S B Andersson; P O Gunnarsson; T Nilsson; G P Forshell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

6.  Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r.

Authors:  M Hansenson; B Lundh; B Hartley-Asp; A Pousette
Journal:  Urol Res       Date:  1988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.